TIRZEPATIDE

Tirzepatide is a modified 39-amino-acid peptide based on the GIP sequence and characterised as a dual agonist at GIP and GLP-1 receptors. Authorised tirzepatide medicines exist, but this Auren listing is a separate research material and is not supplied as a medicine.

Research includes receptor binding and signalling, biased agonism, glucose-dependent endocrine pathways and metabolic models. Medicine-specific dosing, indications and clinical claims do not apply to this research-only material.

Sequence length

39 amino acids

Molecular formula

C225H348N48O68

Molecular weight

4813 g/mol

CAS number

2023788-19-2

PubChem CID

156588324

Form

Lyophilised powder

Registry values can differ by salt, counter-ion, hydrate, charge state or supplier representation. The lot certificate takes precedence.

1. 01

   Keep the sealed lyophilised material dry, protected from light and tightly closed.

2. 02

   For longer-term laboratory storage, -20°C is a commonly used condition for peptide reference materials; short-term requirements vary by sequence and formulation.

3. 03

   After preparing a laboratory solution, minimise time at room temperature and repeated freeze-thaw cycles. The lot-specific label, CoA and SDS take priority over general guidance.